Anavex Life Sciences (AVXL) EBIT Growth (3y) (2019 - 2025)
Anavex Life Sciences (AVXL) EBIT Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.78% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - | 28.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.33% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | -5.09% |
| Mar 31, 2025 | -2.80% |
| Dec 31, 2024 | -5.05% |
| Sep 30, 2024 | -28.28% |
| Jun 30, 2024 | -27.54% |
| Mar 31, 2024 | -28.26% |
| Dec 31, 2023 | -41.33% |
| Sep 30, 2023 | -50.41% |
| Jun 30, 2023 | -47.26% |
| Mar 31, 2023 | -73.44% |
| Dec 31, 2022 | -51.92% |
| Sep 30, 2022 | -117.51% |
| Jun 30, 2022 | -112.06% |
| Mar 31, 2022 | -47.97% |
| Dec 31, 2021 | -20.14% |
| Sep 30, 2021 | 248.06% |
| Jun 30, 2021 | 379.97% |
| Mar 31, 2021 | 229.29% |